Israel Englander’s Ibere Pharmaceuticals IBER Stock Holding History

Israel Englander’s Portfolio IBER Stock Details IBER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-114,500	Closed	-$23K	–	7767
2022 Q1	$23K	Sell	114,500 -97,500	-46%	-$950K	﹤0.01%	6615
2021 Q4	$114K	Buy	212,000 +62,500	+42%	+$608K	﹤0.01%	6201
2021 Q3	$89K	Buy	149,500 +52,000	+53%	+$503K	﹤0.01%	6475
2021 Q2	$74K	Buy	+97,500	New	+$949K	﹤0.01%	6314

Israel Englander's IBER Position: Q1 2023 in Review

Israel Englander sold out of Ibere Pharmaceuticals (IBER) in Q1 2023, closing a stake of 660,664 shares — an estimated $6.67M sold.

Israel Englander first reported a position in IBER in Q2 2021 and held it in 7 quarters. The position peaked at $6.67M in Q4 2022. 0 funds tracked by Wall St. Rank hold IBER as of Q1 2023.

Israel Englander reported no remaining Ibere Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Israel Englander sold 660,664 Ibere Pharmaceuticals shares in Q1 2023, an estimated $6.67M.
Israel Englander first reported a position in Ibere Pharmaceuticals in Q2 2021 and held it in 7 quarters.
Israel Englander's Ibere Pharmaceuticals position peaked at $6.67M in Q4 2022.
0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.